Anna Pagotto
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The natural mutation Arg221aTrp in human α-thrombin abrogates physiological Na+ binding and preferentially hinders the protease anticoagulant functions.
Journal: Journal of thrombosis and haemostasis : JTH
Published: January 07, 2026
The main protease (Mpro) from SARS-CoV-2 triggers plasma clotting in vitro by activating coagulation factors VII and FXII.
Journal: Communications biology
Published: October 17, 2024
Mechanistic basis of activation and inhibition of protein disulfide isomerase by allosteric antithrombotic compounds.
Journal: Journal of thrombosis and haemostasis : JTH
Published: August 14, 2024
From haemadin to haemanorm: Synthesis and characterization of full-length haemadin from the leech Haemadipsa sylvestris and of a novel bivalent, highly potent thrombin inhibitor (haemanorm).
Journal: Protein science : a publication of the Protein Society
Published: June 16, 2023
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation.
Journal: Scientific reports
Published: September 14, 2021
Staphylococcus aureus iron-regulated surface determinant B (IsdB) protein interacts with von Willebrand factor and promotes adherence to endothelial cells.
Journal: Scientific reports
Published: August 31, 2021
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.
Journal: Cell death & disease
Published: March 04, 2019
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells.
Journal: Cell death & disease
Published: February 21, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026